We found that FLX treatment of adult mice reduces weight gain both in normal conditions and upon obesity which correlate with higher energy expenditure, increased response to acute leptin and higher hypothalamic BDNF. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.